Event Title

Glucose Transporter Inhibitor DRB18 in the Treatment of Lung Cancer

Abstract

DRB18 is a new anticancer compound that blocks glucose uptake in cancer cells and works with other drugs to improve outcomes.

Keywords:

Biological Sciences, Cancer, Biomedical Sciences, Anticancer drugs, Cancer metabolism, video

Comments

Presenter email: lb148917@ohio.edu

Status

Undergraduate

Department

Biological Sciences

College

Honors Tutorial College

Campus

Athens

Faculty Mentor

Chen, Xiaozhuo

Creative Commons License

Creative Commons Attribution-Noncommercial-No Derivative Works 4.0 License
This work is licensed under a Creative Commons Attribution-Noncommercial-No Derivative Works 4.0 License.

Streaming Media

Share

COinS
 

Glucose Transporter Inhibitor DRB18 in the Treatment of Lung Cancer

DRB18 is a new anticancer compound that blocks glucose uptake in cancer cells and works with other drugs to improve outcomes.